Gold Nanoparticle-Bioconjugated Aminoguanidine Inhibits Glycation Reaction: An In Vivo Study in a Diabetic Animal Model

Proteins undergo glycation resulting in the generation of advanced glycation end products (AGEs) that play a central role in the onset and advancement of diabetes-associated secondary complications. Aminoguanidine (AG) acts as an antiglycating agent by inhibiting AGE generation by blocking reactive...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Biomed Res Int
Main Authors: Ahmad, Saheem, Khan, Mohd. Sajid, Alouffi, Sultan, Khan, Saif, Khan, Mahvish, Akashah, Rihab, Faisal, Mohammad, Shahab, Uzma
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi 2021
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8137289/
https://ncbi.nlm.nih.gov/pubmed/34055984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/5591851
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares